ArticleJournal of the American Heart Association2025
Incidence of Right Ventricular Dysfunction in an Echocardiographic Referral Cohort.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
backgroundIncidence rates of right ventricular dysfunction (RVD) are unknown. We examined the rates, risk factors, and heart failure (HF) hospitalization hazard associated with incident RVD and right ventricle-pulmonary artery (RV-PA) uncoupling in patients referred for transthoracic echocardiogram (TTE).
methodsIn this retrospective cohort study, we extracted data from TTEs at Vanderbilt University Medical Cente (2010-2023). We followed patients from their earliest TTE with normal right ventricle function (tricuspid annular plane systolic excursion [TAPSE] ≥17 mm). The primary outcomes were new RVD (TAPSE <17 mm) and RV-PA uncoupling (TAPSE/right ventricular systolic pressure <0.36 mm/mm Hg). We evaluated risk factors for and hazard of HF hospitalization associated with each outcome. We estimated incidence rates using the Poisson distribution and hazard ratios using Cox models adjusted for demographics, comorbidities, and TTE measures.
resultsThere were 45 753 patients (aged 63 years [interquartile range, 50-72], 45% men, 13% Black) meeting inclusion criteria. Of the patients, 13 735 had a follow-up TAPSE. The incidence rates of RVD and RV-PA uncoupling were 8.2 per person-year (95% CI, 8.0-8.5) and 3.4 per 100 person-years (95% CI, 3.2-3.6), respectively. Incidence rates increased with rising right ventricular systolic pressure. Risk factors for RVD and RV-PA uncoupling were most prominently HF, atrial fibrillation, and other cardiovascular comorbidities. Baseline right ventricular systolic pressure >35 mm Hg associated with TAPSE declined over time. The hazard of HF hospitalization increased with incident RVD (hazard ratio, 2.02 [95% CI, 1.85-2.21]) or when TAPSE declined by ≥5 mm.
conclusionsRVD incidence is substantial among patients referred for TTE. Clinical monitoring is warranted if right ventricular systolic pressure is >35 mm Hg. Cardiovascular comorbidities drive RVD and RV-PA uncoupling in this population. Incident RVD associates with increased HF hospitalization hazard.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.